dan 2163 and cannabidiol

dan 2163 has been researched along with cannabidiol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Gerth, CW; Hellmich, M; Hoyer, C; Klosterkötter, J; Koethe, D; Leweke, FM; Muhl, D; Pahlisch, F; Piomelli, D	1
Chourdakis, M; Goulas, A; Kopelli, E; Papazisis, G; Samara, M; Siargkas, A	1

Reviews

1 review(s) available for dan 2163 and cannabidiol

Article	Year
The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis. Psychiatry research, 2020, Volume: 291 Topics: Amisulpride; Antipsychotic Agents; Cannabidiol; Double-Blind Method; Humans; Plant Oils; Randomized Controlled Trials as Topic; Schizophrenia; Treatment Outcome	2020

Trials

1 trial(s) available for dan 2163 and cannabidiol

Article	Year
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational psychiatry, 2012, Mar-20, Volume: 2 Topics: Acute Disease; Adult; Amides; Amisulpride; Antipsychotic Agents; Arachidonic Acids; Cannabidiol; Double-Blind Method; Drug Therapy, Combination; Endocannabinoids; Ethanolamines; Female; Humans; Male; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Sulpiride; Young Adult	2012

Article

Year

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

Translational psychiatry, 2012, Mar-20, Volume: 2

Topics: Acute Disease; Adult; Amides; Amisulpride; Antipsychotic Agents; Arachidonic Acids; Cannabidiol; Double-Blind Method; Drug Therapy, Combination; Endocannabinoids; Ethanolamines; Female; Humans; Male; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Sulpiride; Young Adult

2012